STOCK TITAN
  1. Home
  2. Financials
  3. FLNA
  4. EPS (Diluted)

Filana Therapeutics (FLNA) EPS by Year

FLNA NASDAQ

Filana Therapeutics, Inc. lost $1.88 per diluted share in fiscal year 2025. The table below carries 15 fiscal years, from 2011 to 2025, and the quarters Filana Therapeutics, Inc. has filed alongside them.

FY2025 annual
EPS (Diluted) -$1.88

Ticker history: SAVA became FLNA (Filana Therapeutics, Inc.) on . Earlier news and filings retain their original names and dates. View SAVA history.

Source SEC Filings Latest period Q2 FY2026, ended Jun 30, 2026 Reported Currency USD

Annual figures, oldest first. Point at a bar to read its period.

FLNA EPS (Diluted) by Fiscal Year

Figures are as reported in USD. Each change compares the year with the year before it, and each column links to the filing it was taken from.

MetricFY25FilingFY24FilingFY23FilingFY22FilingFY21FilingFY20FilingFY19FilingFY18FilingFY17FilingFY16FilingFY15FilingFY14FilingFY13FilingFY12FilingFY11Filing
EPS (Diluted)-$1.88-$1.46-$2.32n/m-$1.90n/m-$0.82n/m-$0.24-$0.27-$0.61-$1.82-$2.28-$0.31n/m-$0.27-138.6%$0.70n/m-$0.08n/m-$0.06

FLNA EPS (Diluted) by Quarter

Figures are as reported in USD. Each change compares the quarter with the same quarter a year earlier.

MetricQ2'2610-QQ1'2610-QQ4'2510-QQ3'25FilingQ2'25FilingQ1'2510-QQ4'24FilingQ3'24FilingQ2'24FilingQ1'24FilingQ4'23FilingQ3'23Filing
EPS (Diluted)N/AN/A-$0.26n/m-$0.22n/m-$0.92-807.7%-$0.48n/m-$0.58n/m-$0.58n/m$0.13n/m-$0.43n/m-$0.50-$0.61

What diluted earnings per share means

Diluted earnings per share divides net income by the share count the company would have if every option and convertible security were exercised, which is the more conservative of the two per-share figures a filer reports.

More Filana Therapeutics, Inc. financials

Frequently Asked Questions

Filana Therapeutics, Inc. lost $1.88 per diluted share in fiscal year 2025.

Across the 15 fiscal years this page covers, Filana Therapeutics, Inc. (FLNA) diluted earnings per share went from -$0.06 in fiscal year 2011 to -$1.88 in fiscal year 2025.

Diluted earnings per share divides net income by the share count the company would have if every option and convertible security were exercised, which is the more conservative of the two per-share figures a filer reports. This page lists what Filana Therapeutics, Inc. (FLNA) reported on that line in every period on record.